[Kala-azar in immunosuppressed patients. Apropos of a case disclosed by skin lesions].
PubMed
November 10, 1984
Cited by 9
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients
|Lara D. Veeken|2011|170
Systemic mastocytosis and bone involvement in a cohort of 75 patients
|Annals of the Rheumatic Diseases|2010|163